Literature DB >> 23664493

Optimal type I and type II error pairs when the available sample size is fixed.

John P A Ioannidis1, Iztok Hozo, Benjamin Djulbegovic.   

Abstract

OBJECTIVE: To model how to select the optimal pair of type I and type II errors that maximize study value when there are constrains on the available study sample size. STUDY DESIGN AND
SETTING: Correct inferences [true positives (TPs) and true negatives (TNs)] increase and wrong inferences (false positives and false negatives) decrease the value of a study. We model the composite value of a study based on these four inferences, their relative importance, and relative frequency using multiplicative and additive models. Numerical examples are presented for randomized trials, epidemiologic studies, and agnostic omics investigations with massive testing and variable sample size constraints.
RESULTS: The optimal choice of type I and type II errors varies a lot according to the available sample size and the plausible effect sizes in each field. We show how equations can be streamlined for special applications: when the value of all four inferences is considered equal, when the identification of TNs carries no value, and when a study carries no value unless at least one TP is discovered.
CONCLUSION: The proposed optimization equations can be used to guide the selection of the optimal type I and type II errors of future studies in which sample size is constrained.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23664493     DOI: 10.1016/j.jclinepi.2013.03.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Confidence and precision increase with high statistical power.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

Review 2.  Studying Cellular Signal Transduction with OMIC Technologies.

Authors:  Benjamin D Landry; David C Clarke; Michael J Lee
Journal:  J Mol Biol       Date:  2015-08-03       Impact factor: 5.469

3.  New Developments in Non-invasive Brain Stimulation in Chronic Pain.

Authors:  Timothy J Meeker; Rithvic Jupudi; Frederik A Lenz; Joel D Greenspan
Journal:  Curr Phys Med Rehabil Rep       Date:  2020-05-11

4.  Scientific rigor and the art of motorcycle maintenance.

Authors:  Marcus Munafò; Simon Noble; William J Browne; Dani Brunner; Katherine Button; Joaquim Ferreira; Peter Holmans; Douglas Langbehn; Glyn Lewis; Martin Lindquist; Kate Tilling; Eric-Jan Wagenmakers; Robi Blumenstein
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

Review 5.  A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?

Authors:  Ana Rath; Valérie Salamon; Sandra Peixoto; Virginie Hivert; Martine Laville; Berenice Segrestin; Edmund A M Neugebauer; Michaela Eikermann; Vittorio Bertele; Silvio Garattini; Jørn Wetterslev; Rita Banzi; Janus C Jakobsen; Snezana Djurisic; Christine Kubiak; Jacques Demotes-Mainard; Christian Gluud
Journal:  Trials       Date:  2017-11-22       Impact factor: 2.279

6.  The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.

Authors:  T Burt; K S Button; Hhz Thom; R J Noveck; M R Munafò
Journal:  Clin Transl Sci       Date:  2017-07-04       Impact factor: 4.689

7.  Flexible Data Trimming Improves Performance of Global Machine Learning Methods in Omics-Based Personalized Oncology.

Authors:  Victor Tkachev; Maxim Sorokin; Constantin Borisov; Andrew Garazha; Anton Buzdin; Nicolas Borisov
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.